Clin Exp Vaccine Res.  2013 Jul;2(2):120-127. 10.7774/cevr.2013.2.2.120.

Current status of production and market of human vaccine products in Korea

• Kim SY
• Cho J
• Cha SH
• Bae CW

• KMID: 2167722
• DOI: http://doi.org/10.7774/cevr.2013.2.2.120

Abstract

PURPOSE
The goal of this study was to build basic information related to the production and market of human vaccine products in Korea, which can be an important indicator to provide basic data in practical use.
MATERIALS AND METHODS
Statistical data were obtained from the Bank of Korea, Korea Health Industry Development Institute, Korea Pharmaceutical Traders Association, and Korea Pharmaceutical Manufacturers Association.
RESULTS
Vaccines are the 10th ranked drugs in the classification of whole complete preparated drugs. The production output of vaccines in Korea was 392.2 billion KRW in 2011, comprising 2.83% of complete preparated drug production output (13 trillion 880.8 billion KRW) and 2.54% of medical-pharmaceutical product output (15 trillion 440.3 billion KRW). The market scale of vaccines in Korea was 710 billion KRW in 2011, with an annual average growth rate of 11% in the past 6 years, comprising 2% of vaccine market in the world. There was also a significant increase in essential vaccines and other preventive vaccines in a global scale.
CONCLUSION
Vaccines have the potential of becoming an emerging attractive industry. Based on the current analysis about the production of vaccine products and market scale, further development of the vaccine industry is expected in Korea.

Keyword

Vaccine; Vaccination; Immunization; Drugs; Drug industry; Drug production; Marketing of health services; Korea

MeSH Terms

Drug Industry
Humans
Immunization
Korea
Marketing of Health Services
Vaccination
Vaccines
Vaccines

Reference

1. Economic Statistics System, The Bank of Korea [Internet]. Seoul: Economic Statistics System;c2010. cited 2013 Mar 1. Available from: http://ecos.bok.or.kr/.

2. 2012 Korea Pharmaceutical Industry Statistics [Internet]. Seoul: Korea Pharmaceutical Manufacturers Association;c2009. cited 2013 Mar 1. Available from: http://www.kpma.or.kr/index.php?mid=KW07_04_html.

3. Lim DO, Shin YW, Yoon SY, Chung MJ, Lee SW. 2012 Korea Pharmaceutical Industry Survey Report. Cheongwon: Korea Health Industry Development Institute;2012. 12. p. 49–65.

4. Korea Health Industry Statistics System, Korea Health Industry Development Institute. Medical drug [Internet]. Cheongwon: Korea Health Industry Statistics System;c2008. ctied 2013 Mar 1. Available from: http://www.khiss.go.kr/.

5. Korea Pharmaceutical Traders Association. 2012 Facts and survey report [Internet]. Seoul: Korea Pharmaceutical Traders Association;cited 2013 Mar 1. Available from: http://www.kpta.or.kr/main/main.asp.

6. Park JT. Establishment of Nationality in vaccine industry in Korea: many potentials and new industry. Health Industry Trend. Vol 14. Cheongwon: Korea Health Industry Development Institute;2013. p. 2–9.

7. Newsletter for National Immunization Program. Cheongwon: Korea Centers for Disease Control and Prevention;2013. 01. p. 1–17.